In recent years, nucleic acid drugs are regarded as the third generation of innovative drugs after small molecule drugs and antibody drugs. As the representative of nucleic acid drugs, oligonucleic acid drugs show very rich potential.

The enterprise total solution team has rich experience in process design and project management in oligonucleotide production projects. With the rapid development of oligonucleotide drugs, more and more companies began to invest in the research and development and production of oligonucleotide drugs, Biker is committed to providing the industry with more perfect and efficient enterprise solutions, better meet customer needs, and provide customers with integrated services.